换一批Structurally-engineered fatty acid 1024 (SEFA-1024) improves diet-induced obesity, insulin resistance, and fatty liver disease.
第一作者：
Jordon D,Secor
第一单位：
Vascular Biology Program, Boston Children's Hospital, Boston, Massachusetts, USA.;Department of Surgery, Boston Children's Hospital, Boston, Massachusetts, USA.
作者：
医学主题词
动物(Animals);糖尿病(Diabetes Mellitus);脂肪酸类(Fatty Acids);胰高血糖素样肽1(Glucagon-Like Peptide 1);胰岛素抗药性(Insulin Resistance);脂类代谢(Lipid Metabolism);肝(Liver);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);肥胖症(Obesity);大鼠(Rats)
DOI
10.1002/lipd.12351
PMID
35778847
发布时间
2023-07-03
基金项目
T32 HL007734/HL/NHLBI NIH HHS/United States
F32 DK104525/DK/NIDDK NIH HHS/United States
HHMI/Howard Hughes Medical Institute/United States
- 浏览0
Lipids
241-255页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
